Additional in vitro co-culture experiments with tumor cells and peripheral immune cells, either with or without immune-checkpoint blockade with anti-PD-L1, anti-LAG-3, or a combination of both confirmed the therapeutic activity of these antibodies (Fig. 1C). Here, LAG3 is linked to neoplasm.